TEMMA® — Targeted Embolization for Migraine Management — is a one-time, minimally invasive procedure for severe migraine. It is not a daily medication. It is not a series of injections. It is a single outpatient procedure on a blood vessel linked to migraine pain.
A fellowship-trained neurointerventional specialist threads a hair-thin microcatheter from a small puncture at the wrist or groin up to the middle meningeal artery (MMA) — the blood vessel that feeds the membrane linked to migraine pain. A tiny platinum coil is placed to greatly decrease blood flow to the dura — the membrane surrounding the brain. The embolization takes 40 minutes. Both sides are typically treated in a single session. You go home the same day — drug-free.
The same approach has been used in neurointerventional medicine for decades. Applied to the migraine pathway, it is showing very positive results in early studies for the treatment of migraine.
The entire procedure is built around one small artery. Here is why that works.

A small artery inside the skull, the middle meningeal artery (MMA), supplies the dura — the brain’s pain-sensitive outer lining.
In migraine, the MMA dilates and the dura becomes inflamed, triggering the pain cascade that medications try — and often fail — to control.
Embolization greatly decreases blood flow to the dura, smothering the inflammatory cascade. The procedure takes 40 minutes. You go home the same day — drug-free.
Every other preventive option asks you to keep going — refills, appointments, cycles that start over. TEMMA® is different by design.
First comes a short, same-day test — not the procedure. We deliver a small amount of lidocaine, a common numbing medicine, to the MMA. If your migraine quiets in the days that follow, the pathway is confirmed and TEMMA® is very likely to help. If it does not, we stop. Nothing permanent has happened.
